Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Biochem Cell Biol ; 64: 136-46, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25862283

ABSTRACT

Bax cytosol-to-mitochondria translocation is a central event of the intrinsic pathway of apoptosis. Bcl-xL is an important regulator of this event and was recently shown to promote the retrotranslocation of mitochondrial Bax to the cytosol. The present study identifies a new aspect of the regulation of Bax localization by Bcl-xL: in addition to its role in Bax inhibition and retrotranslocation, we found that, like with Bcl-2, an increase of Bcl-xL expression levels led to an increase of Bax mitochondrial content. This finding was substantiated both in pro-lymphocytic FL5.12 cells and a yeast reporting system. Bcl-xL-dependent increase of mitochondrial Bax is counterbalanced by retrotranslocation, as we observed that Bcl-xLΔC, which is unable to promote Bax retrotranslocation, was more efficient than the full-length protein in stimulating Bax relocation to mitochondria. Interestingly, cells overexpressing Bcl-xL were more sensitive to apoptosis upon treatment with the BH3-mimetic ABT-737, suggesting that despite its role in Bax inhibition, Bcl-xL also primes mitochondria to permeabilization and cytochrome c release.


Subject(s)
Antineoplastic Agents/pharmacology , Biphenyl Compounds/pharmacology , Mitochondria/metabolism , Nitrophenols/pharmacology , Sulfonamides/pharmacology , bcl-2-Associated X Protein/metabolism , bcl-X Protein/metabolism , Animals , Apoptosis , Cell Line , Mice , Piperazines/pharmacology , Protein Multimerization , Protein Transport , Saccharomyces cerevisiae
SELECTION OF CITATIONS
SEARCH DETAIL
...